Validation of a prostate cancer polygenic risk score.
Mary H BlackShuwei LiHolly LaDucaMin-Tzu LoJefferey ChenRobert HoinessStephanie GutierrezBrigette Tippin-DavisHsiao-Mei LuMarta GielzakKathleen WileyZhuqing ShiJun WeiSiqun Lilly ZhengBrian T HelfandWilliam B IsaacsJianfeng XuPublished in: The Prostate (2020)
These data suggest that a 72-SNP PRS is predictive of PrCa, supporting its potential use in clinical risk assessment.